Onyx Biotec IPO Sales, Profits, and other Financial Details - What you should know about the Onyx Biotec IPO

Onyx Biotec IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Onyx Biotec Limited IPO
The Revenues from operations for the Fiscals 2024, 2023 and 2022 were ₹5,387.43 Lakhs, ₹3,961.65 Lakhs and ₹4,498.09 Lakhs, respectively. The EBITDA for the Fiscals 2024, 2023 and 2022 were ₹840.77 Lakhs, ₹459.25 Lakhs and ₹575.79 Lakhs, respectively. The Profit after Tax for the Fiscals 2024, 2023 and 2022 was ₹303.16 Lakhs, ₹184.46 Lakhs and ₹335.29 Lakhs, respectively.

Onyx Biotec Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakh)

Period Ended	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	1,155.65	1,230.00	1,047.43
Total Assets	7,413.58	5,872.36	3,683.84
Total Borrowings	3,078.04	2,922.83	1,224.39
Fixed Assets	4,347.72	4,250.39	1,723.49
Cash	146.68	0.74	1.36
Net Borrowing	2,931.36	2,922.09	1,223.03
Revenue	5,387.43	3,961.65	4,498.09
EBITDA	840.77	459.25	575.79
PAT	303.16	184.46	335.29
EPS	2.54	1.56	2.84

Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in Price Band Advertisement.